T.J. Dillashaw continues to receive criticism after accepting a two-year ban from the United States Anti-Doping Agency (USADA) as a result of a positive drug test.
On March 20, Dillashaw announced that he would be relinquishing his bantamweight belt after USADA and the New York State Athletic Commission (NYSAC) found adverse findings in a drug-test taken before his last fight against Henry Cejudo. The NYSAC suspended Dillashaw for one-year as a result of the findings before USADA slapped him with a two-year ban for recombinant human erythropoietin (EPO) use which was retroactive from his fight against Henry Cejudo on Jan.